Timothy Morris
Direktor/Vorstandsmitglied bei AQUESTIVE THERAPEUTICS, INC.
Vermögen: 15 962 $ am 30.04.2024
Profil
Timothy E.
Morris was the founder of Mvhs Theatre Friends, Inc. (founded in 2014) where he served as the Director.
He is currently working as an Independent Director at Aquestive Therapeutics, Inc., DBV Technologies SA, Humanetics Corp., and Univercells SA. He also holds director positions at Humanigen Ltd., Humanigen Australia Pty Ltd., and Humanigen Europe Ltd.
Mr. Morris previously worked as a Non-Executive Director at PAION, Inc. from 2015 to 2017.
He was the Chief Financial & Accounting Officer at Glycomed, Inc. from 1992 to 1995.
From 2004 to 2013, he served as the SVP-Finance & Global Corporate Development at VIVUS, Inc. He held the position of CFO, Vice President-Finance & Administration at RiboGene, Inc. from 1995 to 1999.
Mr. Morris was a Senior Manager at Ernst & Young LLP from 1984 to 1992.
He also worked as the CFO, SVP-Finance & Administration at Questcor Pharmaceuticals, Inc. from 2001 to 2004.
From 2016 to 2022, he served as the Chief Operating & Financial Officer at Humanigen, Inc. He was the Chief Financial Officer at Opthea Ltd.
from 2022 to 2023.
Mr. Morris also held the position of Chief Financial Officer at Utility.com and InterPro, Inc. He was the CFO & Head-Business Development at Talphera, Inc. from 2014 to 2017.
Additionally, he served as the Chief Financial Officer at Iovance Biotherapeutics, Inc. in 2017.
Mr. Morris completed his undergraduate degree at California State University-Chico.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
DBV TECHNOLOGIES SA
0,01% | 29.02.2024 | 12 000 ( 0,01% ) | 15 962 $ | 30.04.2024 |
| 22.03.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Timothy Morris
| Unternehmen | Position | Beginn |
|---|---|---|
| DBV TECHNOLOGIES | Direktor/Vorstandsmitglied | 30.03.2021 |
| AQUESTIVE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 10.08.2022 |
Univercells SA
 Univercells SA BiotechnologyHealth Technology Univercells SA designs single-use cost-efficient bioprocess solutions to open the next chapter in bio manufacturing. The company was founded by Jose Castillo, Guillaume De Viron and Hugues Bultot in 2013 and is headquartered in Gosselies, Belgium. | Direktor/Vorstandsmitglied | 01.08.2022 |
Humanetics Corp.
 Humanetics Corp. Pharmaceuticals: MajorHealth Technology Humanetics Corp. engages in development and commercialization of bioactive compounds. Its products include radiation modulators, mechanism of action, safety and toxicology, and pharmacokinetics. It focuses on oncology, medical imaging, and medical countermeasures. The company was founded by Ronald J. Zenk in 1988 and is headquartered in Edina, MN. | Direktor/Vorstandsmitglied | 26.10.2021 |
Ehemalige bekannte Positionen von Timothy Morris
| Unternehmen | Position | Ende |
|---|---|---|
| OPTHEA LIMITED | Finanzdirektor/CFO | 27.10.2023 |
| HUMANIGEN, INC. | Finanzdirektor/CFO | 23.10.2022 |
| IOVANCE BIOTHERAPEUTICS, INC. | Finanzdirektor/CFO | 10.06.2020 |
| TALPHERA, INC. | Finanzdirektor/CFO | 02.06.2017 |
Ausbildung von Timothy Morris
| California State University-Chico | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 6 |
|---|---|
| TALPHERA, INC. | Health Technology |
| HUMANIGEN, INC. | Health Technology |
| IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
| DBV TECHNOLOGIES | Health Technology |
| AQUESTIVE THERAPEUTICS, INC. | Health Technology |
| OPTHEA LIMITED | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Glycomed, Inc.
 Glycomed, Inc. Pharmaceuticals: MajorHealth Technology Glycomed, Inc. discovers and developes pharmaceuticals based on complex carbohydrates. The company's drug discovery strategy utilizes medicinal chemistry to identify biologically active small molecules for therapeutic use. The company was founded by Brian G. Atwood in 1987 and is headquartered in San Diego, CA. | Health Technology |
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
RiboGene, Inc.
 RiboGene, Inc. BiotechnologyHealth Technology RiboGene, Inc. manufactures biological products. It discovers and develops new classes of compounds that act through the translational control of gene expression. The company is headquartered in Hayward, CA | Health Technology |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Questcor Pharmaceuticals, Inc.
 Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
InterPro, Inc.
 InterPro, Inc. Miscellaneous Commercial ServicesCommercial Services InterPro, Inc. provides business process outsourcing services. The company was founded by David C. Lucien and is headquartered in Rockville, MD. | Commercial Services |
Humanetics Corp.
Humanetics Corp. Pharmaceuticals: MajorHealth Technology Humanetics Corp. engages in development and commercialization of bioactive compounds. Its products include radiation modulators, mechanism of action, safety and toxicology, and pharmacokinetics. It focuses on oncology, medical imaging, and medical countermeasures. The company was founded by Ronald J. Zenk in 1988 and is headquartered in Edina, MN. | Health Technology |
Univercells SA
Univercells SA BiotechnologyHealth Technology Univercells SA designs single-use cost-efficient bioprocess solutions to open the next chapter in bio manufacturing. The company was founded by Jose Castillo, Guillaume De Viron and Hugues Bultot in 2013 and is headquartered in Gosselies, Belgium. | Health Technology |
